Cargando…

Development and Evaluation of the Personal Patient Profile-Prostate (P3P), a Web-Based Decision Support System for Men Newly Diagnosed With Localized Prostate Cancer

BACKGROUND: Given that no other disease with the high incidence of localized prostate cancer (LPC) has so many treatments with so few certainties related to outcomes, many men are faced with assuming some responsibility for the treatment decision along with guidance from clinicians. Men strongly con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berry, Donna L, Halpenny, Barbara, Wolpin, Seth, Davison, B Joyce, Ellis, William J, Lober, William B, McReynolds, Justin, Wulff, Jennifer
Formato:	Texto
Lenguaje:	English
Publicado:	Gunther Eysenbach 2010
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056527/ https://www.ncbi.nlm.nih.gov/pubmed/21169159 http://dx.doi.org/10.2196/jmir.1576

Ejemplares similares

Personal preferences and discordant prostate cancer treatment choice in an intervention trial of men newly diagnosed with localized prostate cancer
por: Bosco, Jaclyn LF, et al.
Publicado: (2012)

Exposure to a Patient-Centered, Web-Based Intervention for Managing Cancer Symptom and Quality of Life Issues: Impact on Symptom Distress
por: Berry, Donna L, et al.
Publicado: (2015)

The electronic self report assessment and intervention for cancer: promoting patient verbal reporting of symptom and quality of life issues in a randomized controlled trial
por: Berry, Donna L, et al.
Publicado: (2014)

Detection of antibodies directed at M. hyorhinis p37 in the serum of men with newly diagnosed prostate cancer
por: Urbanek, Cydney, et al.
Publicado: (2011)

Cost-effectiveness of Prostate Radiation Therapy for Men With Newly Diagnosed Low-Burden Metastatic Prostate Cancer
por: Lester-Coll, Nataniel H., et al.
Publicado: (2021)

Multidisciplinary Therapy in Men with Newly Diagnosed Oligometastatic Prostate Cancer
por: Watanabe, Kazuhiro, et al.
Publicado: (2021)

Assigning value to preparation for prostate cancer decision making: a willingness to pay analysis
por: Wilson, Leslie S., et al.
Publicado: (2019)

Usability evaluation and adaptation of the e-health Personal Patient Profile-Prostate decision aid for Spanish-speaking Latino men
por: Berry, Donna L., et al.
Publicado: (2015)

A Pilot Trial of Pembrolizumab plus Prostatic Cryotherapy for Men with Newly Diagnosed Oligometastatic Hormone-Sensitive Prostate Cancer
por: Ross, Ashley E., et al.
Publicado: (2019)

Multidisciplinary total eradication therapy (TET) in men with newly diagnosed oligometastatic prostate cancer
por: Reyes, D. K., et al.
Publicado: (2020)

Concordance between influential adverse treatment outcomes and localized prostate cancer treatment decisions
por: Pozzar, Rachel A., et al.
Publicado: (2022)

Health care delivery system contributions to management of newly diagnosed prostate cancer
por: Krampe, Noah, et al.
Publicado: (2023)

Results of Phase 1 study on cytoreductive radical prostatectomy in men with newly diagnosed metastatic prostate cancer
por: Yuh, Bertram E., et al.
Publicado: (2019)

Predictors of survival outcomes in native sub Saharan black men newly diagnosed with metastatic prostate cancer
por: Bello, Jibril Oyekunle
Publicado: (2017)

Baseline Lower Urinary Tract Symptoms and Sexual Dysfunction in Men with Newly Diagnosed Localized Prostate Cancer
por: Song, Wan, et al.
Publicado: (2023)

Dramatic mixed response of lymphangitic pulmonary metastases in newly diagnosed prostate cancer
por: Gorshein, Elan, et al.
Publicado: (2017)

The changing landscape in the management of newly diagnosed castration sensitive metastatic prostate cancer
por: Parker, Daniel C., et al.
Publicado: (2020)

The Automated Bone Scan Index as a Predictor of Response to Prostate Radiotherapy in Men with Newly Diagnosed Metastatic Prostate Cancer: An Exploratory Analysis of STAMPEDE’s “M1|RT Comparison”
por: Ali, Adnan, et al.
Publicado: (2020)

The Influence of Companion Animals on Quality of Life of Gay and Bisexual Men Diagnosed with Prostate Cancer
por: Wright, Morgan M., et al.
Publicado: (2019)

Capturing Relevant Patient Data in Clinical Encounters Through Integration of an Electronic Patient-Reported Outcome System Into Routine Primary Care in a Boston Community Health Center: Development and Implementation Study
por: Loo, Stephanie, et al.
Publicado: (2020)

Prostate cryoablation combined with androgen deprivation therapy for newly diagnosed metastatic prostate cancer: a propensity score-based study
por: wang, Ning, et al.
Publicado: (2021)

Bone Scintigraphy in Staging of Newly Diagnosed Prostate Cancer in Regard of Different Risk Groups
por: Sevcenco, Sabina, et al.
Publicado: (2019)

Health-related quality of life in patients newly diagnosed with prostate cancer: CAPLIFE study
por: Lozano-Lorca, Macarena, et al.
Publicado: (2022)

Technical Description of the Distribute Project: A Community-based Syndromic Surveillance System Implementation
por: Lober, William B., et al.
Publicado: (2014)

Non-invasive Urine Test for Molecular Classification of Clinical Significance in Newly Diagnosed Prostate Cancer Patients
por: Guo, Jinan, et al.
Publicado: (2021)

Models predicting survival to guide treatment decision-making in newly diagnosed primary non-metastatic prostate cancer: a systematic review
por: Thurtle, David, et al.
Publicado: (2019)

Ethnographic investigation of patient–provider communication among African American men newly diagnosed with prostate cancer: a study protocol
por: Palmer, Nynikka R, et al.
Publicado: (2020)

Interobserver agreement of [(68)Ga]Ga-PSMA-11 PET/CT images interpretation in men with newly diagnosed prostate cancer
por: Derwael, Céline, et al.
Publicado: (2020)

Diagnosing hereditary cancer predisposition in men with prostate cancer
por: Pritzlaff, Mary, et al.
Publicado: (2020)

When to perform bone scintigraphy in patients with newly diagnosed prostate cancer? a retrospective study
por: Lin, Yiwei, et al.
Publicado: (2017)

Circulating Prostate Cells Found in Men with Benign Prostate Disease Are P504S Negative: Clinical Implications
por: Murray, Nigel P., et al.
Publicado: (2013)

Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial
por: Parker, Christopher C, et al.
Publicado: (2018)

Prognostic significance of early changes in serum biomarker levels in patients with newly diagnosed metastatic prostate cancer
por: Narita, Shintaro, et al.
Publicado: (2019)

Current treatment options for newly diagnosed metastatic hormone-sensitive prostate cancer—a narrative review
por: Ong, Sean, et al.
Publicado: (2021)

Survival modelling and cost-effectiveness analysis of treatments for newly diagnosed metastatic hormone-sensitive prostate cancer
por: Barbier, Michaela C., et al.
Publicado: (2022)

The role of caregivers in the clinical pathway of patients newly diagnosed with breast and prostate cancer: A study protocol
por: Cincidda, Clizia, et al.
Publicado: (2022)

Increased P-wave dispersion in patients with newly diagnosed lichen planus
por: Sahin, Musa, et al.
Publicado: (2013)

(18)F-DCFPyL PET/CT in Newly Diagnosed Prostate Cancer: Diagnostic Value of Intraprostatic PSMA Uptake in Risk Classification of Prostate Cancer
por: Zhou, Shuoming, et al.
Publicado: (2022)

The SARS-CoV heptad repeat 2 exhibits pH-induced helix formation
por: Celigoy, Jessica, et al.
Publicado: (2011)

Prostate cancer in multi‐ethnic Asian men: Real‐world experience in the Malaysia Prostate Cancer (M‐CaP) Study
por: Lim, Jasmine, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2fkasipeqr6b11ghu09hv0555g